THR Technologies

THR Technologies, a division of Quicksilver Scientific, represents the Leading Edge of Nutraceutical Cannabis. THR licenses the industry-leading nutraceutical delivery technology developed by Quicksilver Scientific to licensed cannabis-infused product manufacturers to produce completely water-dispersible cannabinoid nano emulsions (20-40 nm) for controlled-dosage oral serums and beverage concentrates.

Fast-acting controlled-dosage nano serums provide medical cannabis patients with an alternative to smoking flower or consuming cannabis-infused tinctures, gummies, etc. THR Technologies is committed to supporting the needs of patients, progressive health care practitioners and dispensaries by providing a turnkey system for producing predictable controlled-dosage/rapid uptake cannabis-infused products.

The THR Technical Advantage:

• Hemp:

  NanoCalm micro-emulsified hemp extract nano serum (retail, wholesale, private label) and NanoBoost bulk emulsions for beverage applications.

• Cannabis:

  Turnkey solution for the manufacture of controlled-dosage cannabis-infused nano serums through license agreement. These cannabis nano emulsions are also suitable for beverage applications. THR Tech supplies the ingredient premix (no cannabinoids), small-footprint/high capacity pharmaceutical manufacturing equipment and full manufacturing instructions/SOPs.

• Nano Serum Product Development:

  Cannabinoids + Terpenes

  Hemp and cannabis-infused nano serums featuring strain-specific cannabinoid and terpene profiles for optimized user experience.

• Cannabinoids + Nutraceuticals

  Hemp and marijuana nano serums featuring 5-HTP, Tocotrienol, CoQ10, Resveratrol, Vitamins and other herbal compounds (Boswellia, Curcumin, etc.) for differentiation/premium positioning in an increasingly crowded marketplace.

Company details

Website:
https://thrtech.com/

Headquarters:
Imperial Way Watford, Herts

Year founded:
2016

Company type:
Privately Held

Company size:
2-10 employees.